A recent metabolomics study tested the effect of GLS inhibition with CB-839 in undifferentiated pleomorphic sarcoma (UPS) and soft tissue sarcomas and found that GLS inhibition causes tumor cell death (95). The gene discussed is GLS; the disease is neoplasm.